We are experiencing minor difficulties with some of our submission forms, which we are working to resolve. You should still be able to submit items, but if you have any issues while submitting, please contact us at dspace-lib@mit.edu.

Synthesis of (±)-Emtricitabine and (±)-Lamivudine by Chlorotrimethylsilane–Sodium Iodide-Promoted Vorbrüggen Glycosylation

Thumbnail Image
Download
Name

synthesis-of-emtricitabine-and-lamivudine-by-chlorotrimethylsilane-sodium-iodide-promoted-vorbruggen-glycosylation (1).pdf

Description
Submitted version
Size

589.6 KB

Format

Adobe PDF

Checksum (MD5)

819caaf14a2d0ac9bdb266f83bef7fe2

sword-2022-03-09T15:40:53.original.xml (130 B)
Original SWORD entry document
Author(s)
Mear, Sarah Jane
•
Nguyen, Long V
•
Rochford, Ashley J
•
Jamison, Timothy F
Date Issued
January 14, 2022
Journal
The Journal of Organic Chemistry
Publisher
American Chemical Society (ACS)
Citation
Mear, Sarah Jane, Nguyen, Long V, Rochford, Ashley J and Jamison, Timothy F. 2022. "Synthesis of (±)-Emtricitabine and (±)-Lamivudine by Chlorotrimethylsilane–Sodium Iodide-Promoted Vorbrüggen Glycosylation." The Journal of Organic Chemistry.
Version
Original manuscript
Abstract
By simple combination of water and sodium iodide (NaI) with chlorotrimethylsilane (TMSCl), promotion of a Vorbrüggen glycosylation en route to essential HIV drugs emtricitabine (FTC) and lamivudine (3TC) is achieved. TMSCl-NaI in wet solvent (0.1 M water) activates a 1,3-oxathiolanyl acetate donor for N-glycosylation of silylated cytosine derivatives, leading to cis-oxathiolane products with up to 95% yield and >20:1 dr. This telescoped sequence is followed by recrystallization and borohydride reduction, resulting in rapid synthesis of (±)-FTC/3TC from a tartrate diester.
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
10.1021/acs.joc.1c02772
PrivacyPermissionsAccessibilityContact us
Notify us about copyright concerns.